The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index; 20 of the 300 sources its claims cite were checked for support.
Coupling Krebs cycle metabolites to signalling in immunity and cancer
Open accessAbstract
Metabolic reprogramming has become a key focus for both immunologists and cancer biologists, with exciting advances providing new insights into the mechanisms underlying disease. There is now extensive evidence that intermediates and derivatives of the mitochondrial Krebs cycle—metabolites traditionally associated with bioenergetics or biosynthesis—also possess ‘non-metabolic’ signalling functions. In this review, we summarize the non-metabolic signalling mechanisms of succinate, fumarate, itaconate, 2-hydroxyglutarate isomers (d-2-hydroxyglutarate and l-2-hydroxyglutarate) and acetyl-CoA, with a specific focus on how such signalling pathways alter immune cell and transformed cell function. We believe that the insights gained from immune and cancer cells that are summarized here will also be useful for understanding and treating a range of other diseases. Intermediate metabolites of the Krebs cycle serve bioenergetic and biosynthetic needs but have recently also been linked to signalling. The authors of this Review summarize such non-metabolic signalling functions of succinate, fumarate, itaconate, 2-hydroxyglutarate isomers and acetyl-CoA in both immune cells and cancer cells.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that Krebs cycle intermediates—succinate, itaconate, fumarate, 2-HG, and acetyl-CoA—act as signalling molecules in immune cells and cancer beyond bioenergetics. It synthesizes mechanisms by which these metabolites alter inflammation, epigenetics, and tumorigenesis, and discusses therapeutic implications.
Key findings
- Succinate accumulates in LPS/IFN-γ-treated macrophages and promotes inflammation via SUCNR1, HIF-1α stabilization, mtROS/RET at complex I, succinylation, and epigenetic regulation; SDH inhibition by DMM/malonate reduces LPS-induced HIF-1α, IL-1β, and ROS and boosts IL-10/IL-1RA.
- Itaconate, produced by IRG1/CAD from cis-aconitate, is anti-inflammatory: it inhibits SDH, induces Nrf2 via KEAP1 cysteine alkylation (e.g., C151), and can regulate the IκBζ–ATF3 axis; 4-OI was protective in LPS lethality. In peritoneal tumours, tumour-infiltrating macrophage-derived itaconate boosted OXPHOS/mtROS/MAPK and tumour growth.
- Fumarate acts as an oncometabolite and immunomodulator: FH mutations cause HLRCC; fumarate succinates KEAP1, GAPDH, ACO2, and Fe-S proteins, inhibits α-KGDDs/TETs/JMJDs, drives pseudohypoxia and EMT; in β-glucan-trained monocytes fumarate accumulation is required for trained immunity and H3K4me3 at Tnf/Il6.
- 2-HG enantiomers regulate immunity/cancer: D-2-HG from mutant IDH1/2 inhibits α-KGDDs (KDM IC50 24–106 μM; FIH 1.5 mM; PHD2 7.3 mM) and accumulates up to 35 mM in IDH-mutant glioma; L-2-HG rises up to 1.5 mM in TCR-triggered mouse CD8+ T cells and enhances anti-tumour capacity. Acetyl-CoA from citrate via ACLY supports histone acetylation and immune/tumour gene expression.
Methods
- Narrative review; no primary experimental design, sample, or dataset is reported.
- Synthesizes published literature on succinate, itaconate, fumarate, 2-HG, and acetyl-CoA in immunity and cancer; no systematic search strategy, inclusion criteria, or meta-analysis is described.
- Main analysis is conceptual/mechanistic synthesis with figures and therapeutic discussion.
Limitations
- Stated: limited human and in vivo data; rapid steady-state metabolism makes accurate in vivo snapshots challenging; human immune cell studies are limited.
- Stated: many open questions remain about metabolite ratios/compartments, unidentified GPCRs/transporters, and whether metabolites are biomarkers or drivers; oncometabolite findings often come from rare cancer syndromes.
- Evident: as a narrative review, it does not systematically assess evidence quality or quantify bias; many mechanistic claims rely on mouse/cell-line studies and cited primary papers.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
209 Not checked yet · 21 Own interpretation · 10 Couldn’t confirm · 6 No basis given · 3 Partly supported · 1 Supported · accuracy not yet measured
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Treatment of mouse fibroblasts with the SDH inhibitor 3-nitropropionic acid increases succinylation38.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinylation as a covalent modification to regulate multiple targets
What the sources say
- Could not verifycites [38] Jin, Z., Wei, W., Yang, M., Du, Y. & Wan, Y. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell. Metab. 20, 483–498 (2014). sourceExperimental — accuracy not yet measured
The Results section reports effects of mitochondrial complex I deficiency in mouse macrophages and pups, not treatment of fibroblasts with an SDH inhibitor. Searches for 3-nitropropionic acid, SDH inhibition, fibroblasts, and succinylation found no passage in our copy addressing the claimed effect. (LLM, conf=0.76)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“IRG1 has also been shown to mediate the immunomodulatory effects of CO releasing molecule 2 (CORM2)-induced HMOX1 on TNF-αproduction in both LPS-activated macrophages and in a murine endotoxin shock model69”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Partly supportedcites [69] Nair, S. et al. Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection. J. Exp. Med. 215, 1035–1045 (2018). sourceExperimental — accuracy not yet measured
The Results and discussion reports that Irg1 has been found to suppress TLR-triggered TNF-α production, citing Jamal Uddin et al. (2016). The References identifies that study as concerning heme oxygenase-1/carbon monoxide and LPS-mediated sepsis. This paper does not establish the claimed CORM2-induced mechanism or its effects in both LPS-activated macrophages and a murine endotoxin shock model; its own experiments concern M. tuberculosis infection. (LLM, conf=0.82)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Most recently, an intriguing study in peritoneal tumours (B16 melanoma and ID8 ovarian carcinoma) has demonstrated that tumour-infiltrating macrophages release itaconate which potentiates tumour growth74.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
What the sources say
- Could not verifycites [74] Saito, R. et al. Characterizations of three major cysteine sensors of Keap1 in stress response. Mol. Cell Biol. 36, 271–284 (2015). sourceExperimental — accuracy not yet measured
The Methods describe collecting thioglycolate-elicited peritoneal macrophages, and the Results use them to study Keap1–Nrf2 stress sensing. Searches for itaconate and for B16 melanoma and ID8 ovarian carcinoma found no passage about tumour-infiltrating macrophages releasing itaconate or promoting tumour growth. (LLM, conf=0.78)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Importantly, inhibition of aerobic glycolysis by the specific GAPDH inhibitor heptelidic acid (HA) and 2-deoxyglucose (2-DG) recapitulated the immunomodulatory effects of DMF in vitro, while in vivo administration of HA inhibited the development of experimental autoimmune encephalomyelitis (EAE), a murine model of MS99.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Could not verifycites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). sourceExperimental — accuracy not yet measured
The Results and Discussion describe GAPDH succination and enzyme activity in diabetic rats, not treatment of EAE. Searches for heptelidic acid, HA, EAE, and multiple sclerosis found no passage addressing whether in vivo HA administration inhibits EAE development. (LLM, conf=0.78)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“These data are consistent with previous reports demonstrating that Irg1 acts as an oncogene, driving glioma pathogenesis171.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
What the sources say
- Could not verifycites [171] Osinalde, N. et al. Nuclear phosphoproteomic screen uncovers ACLY as mediator of IL-2-induced proliferation of CD4+ T lymphocytes. Mol. Cell. Proteomics 15, 2076–2092 (2016). sourceExperimental — accuracy not yet measured
The cited paper’s supplied Abstract passage discusses IL-2-mediated T-cell proliferation, and the retrieved Methods and References passages concern ACLY and related signaling; no page numbers were provided. Searches for “Irg1 acts as an oncogene driving glioma pathogenesis” and “Irg1 glioma oncogene” found no passage addressing Irg1 or glioma pathogenesis. (LLM, conf=0.76)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“As mentioned, fumarate also inhibits a variety of α-KGDDs, enzymes involved in multiple cellular processes, from metabolism to signalling and epigenetics90-92”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Could not verifycites [90] Blewett, M. M. et al. Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells. Sci. Signal. 9, rs10 (2016). sourceExperimental — accuracy not yet measured
The Introduction discusses dimethyl fumarate’s proposed effects on cysteine-containing proteins, and the Results report inhibition of T-cell activation by dimethyl fumarate. Searches for α-KGDD, dioxygenase, and 2-oxoglutarate-dependent dioxygenases found no passage in our copy addressing whether fumarate inhibits those enzymes. (LLM, conf=0.74)
- Could not verifycites [91] Angiari, S. & O’Neill, L. A. Dimethyl fumarate: targeting glycolysis to treat MS. Cell Res. 28, 613–615 (2018). sourceExperimental — accuracy not yet measured
The paper’s discussion of protein succination (pp. 613–615) says fumarate can modify many proteins and describes inhibition of GAPDH. Searches for α-KGDDs and α-ketoglutarate-dependent dioxygenases found no passage addressing whether fumarate inhibits that enzyme class. (LLM, conf=0.78)
- Could not verifycites [92] Kornberg, M. D. et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360, 449–453 (2018). sourceExperimental — accuracy not yet measured
The supplied passages and searches for α-KGDDs and α-ketoglutarate-dependent dioxygenases found no discussion of that enzyme class. The paper instead discusses fumarate-mediated inactivation of GAPDH and inhibition of GAPDH by dimethyl fumarate (Abstract; page not provided). That does not establish whether fumarate inhibits α-KGDDs. (LLM, conf=0.72)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Lastly, AOAA ameliorated disease progression in EAE, a disease in which TH17 cells mediate pathology143.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Could not verifycites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). sourceExperimental — accuracy not yet measured
The Results (Sequence Analysis; page not available) concern IDH mutations and outcomes in glioma patients, not AOAA treatment or EAE. Searches for AOAA, experimental autoimmune encephalomyelitis, and TH17 found no passage addressing the attributed claim. (LLM, conf=0.78)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Finally, it was shown that fumarate can drive succination of several members of the family of Iron Sulfur (Fe-S) cluster biogenesis proteins, causing a depletion of Fe-S clusters required for the activity of mitochondrial enzymes, including complex I88.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Partly supportedcites [88] Xiao, M. et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26, 1326–1338 (2012). sourceExperimental — accuracy not yet measured
The Discussion (page not available in our copy) says fumarate can cause aberrant succination of many proteins, including KEAP1. It does not identify Fe-S cluster biogenesis proteins as targets or report Fe-S cluster depletion or an effect on mitochondrial complex I activity. (LLM, conf=0.83)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“D-2-HG produced by mIDH1/2 has been shown to drive a CpG island methylator phenotype (G-CIMP) in both glioma and ICC tumours to promote tumorigenesis, and has also been found to occupy the active site of histone demethylases thereby increasing histone methylation in primary gliomas121,123-125.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
- Could not verifycites [123] Rzem, R. et al. A gene encoding a putative FAD-dependent l-2-hydroxyglutarate dehydrogenase is mutated in l-2-hydroxyglutaric aciduria. Proc. Natl. Acad. Sci. USA 101, 16849–16854 (2004). sourceExperimental — accuracy not yet measured
The paper’s Pathophysiological Implications section discusses accumulation and possible toxicity of L-2-hydroxyglutarate in L-2-hydroxyglutaric aciduria (page not available in our copy). Searches for mutant IDH, CpG island methylation, glioma, ICC, and histone demethylation found no passage addressing the attributed tumour mechanism. (LLM, conf=0.78)
- Not checked yetcites [124] Struys, E. A. et al. Mutations in the d-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 76, 358–360 (2005). source
- Not checked yetcites [125] Topçu, M. et al. l-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum. Mol. Genet. 13, 2803–2811 (2004). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“It has been reported that under conditions of hypoxia L-2HG is selectively produced by mammalian cells 51.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Could not verifycites [51] Du, J. et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806–809 (2011). sourceExperimental — accuracy not yet measured
The supplied passages on Sirt5 activity and lysine succinylation (section labeled Abstract; page unavailable) do not address L-2HG production under hypoxia. Searches for hypoxic L-2HG production returned no passage in our copy that speaks to the claim. (LLM, conf=0.76)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“DMM could also decrease inflammation in a mouse model of sepsis28.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Could not verifycites [28] Rasola, A., Neckers, L. & Picard, D. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells. Trends Cell Biol. 24, 455–463 (2014). sourceExperimental — accuracy not yet measured
The section on TRAP1, respiration, and cancer discusses succinate accumulation and tumor growth, not DMM or sepsis. Searches for DMM and dimethyl malonate in relation to inflammation in a mouse sepsis model found no passage addressing the claim in our copy. (LLM, conf=0.78)
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
In the paper
“A selective antagonist for human and rat has been shown to be protective in hypertension, a disease in which succinate is elevated11.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [11] Hollander, A. P., Corke, K. P., Freemont, A. J. & Lewis, C. E. Expression of hypoxia-inducible factor 1α by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum. 44, 1540–1544 (2001). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“LPS can also stabilize HIF-1α indirectly, by increasing succinate levels.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“It transcriptionally directs a switch in metabolism from oxidative phosphorylation to glycolysis, which allows rapid ATP production without the need for oxygen15.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [15] Lewis, G. D. et al. Metabolic signatures of exercise in human plasma. Sci. Transl. Med. 2, 33ra37 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“HIF-1α is tightly regulated by prolyl hydroxylases (PHD), a class of α-ketoglutarate (α-KG)-dependent dioxygenases (α-KGDDs) that convert α-KG to succinate and use molecular oxygen to hydroxylate HIF-1α.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Priming of DCs with succinate and antigen simultaneously, elevates antigen-specific T cell activation, increasing TNFα and IFN-γproduction from these cells4.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“More recently, however, it has been demonstrated that succinate accumulation in tumours promotes angiogenesis via upregulation of vascular endothelial growth factor (VEGF) in a HIF-1α-independent manner.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [23] Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271–275 (1999). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“SUCNR1 ligation on MoDC or the U937 macrophage cell line induces cell migration, suggesting that succinate can act as a chemokine4.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Tissue and circulating succinate is also elevated in other chronic inflammatory settings such as models of diet-induced obesity8.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [8] Schneider, C. et al. A metabolite-triggered tuft cell–ILC2 circuit drives small intestinal remodeling. Cell 174, 271–284.e14 (2018). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“It was demonstrated that brown adipocytes possess a unique capacity to sequester extracellular succinate, which serves to increase UCP1 activity as a consequence of elevated mtROS160.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [160] Chesnelong, C. et al. Lactate dehydrogenase A silencing in IDH mutant gliomas. Neuro-Oncol. 16, 686–695 (2014). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Succinate instead activates extracellular regulated kinase (ERK) 1/2 and signal transducer and activator of transcription 3 (STAT3) in a SUCNR1-dependent manner23.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [23] Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271–275 (1999). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“This correlates with an observed increase in succinate in synovial fluids from rheumatoid arthritis (RA) patients suggesting that chronically elevated succinate is pathological in this setting6.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [6] Lei, W. et al. Activation of intestinal tuft cell-expressed Sucnr1 triggers type 2 immunity in the mouse small intestine. Proc. Natl Acad. Sci. USA. 115, 5552–5557 (2018). source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Ligation of TLR4 by LPS can transcriptionally induce HIF-1α and the induction of a range of HIF-1α target genes under hypoxic and also normoxic conditions2, in an NF-κB-dependent manner19.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
- Not checked yetcites [19] Tannahill, G. M. & O’Neill, L. A. The emerging role of metabolic regulation in the functioning of Toll-like receptors and the NOD-like receptor Nlrp3. FEBS Lett. 585, 1568–1572 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Macrophage activation and IL-1β production are decreased in the absence of SUCR1 both following LPS treatment and in a model of antigen-induced arthritis.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [5] Rubic, T. et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9, 1261–1269 (2008). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Intriguingly, HIF-1α expression is also increased in synovial joints of RA patients7 suggesting that succinate may act in two ways to increase inflammation in RA: via SUCNR1 and HIF-1α.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [7] Nadjsombati, M. S. et al. Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit. Immunity 49, 33–41.e7 (2018). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“HIF-1α is vital for the switch to glycolysis observed in M1 macrophages and DCs following stimulation.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Littlewood-Evans and colleagues (2016) have demonstrated that succinate can act in an autocrine and paracrine manner to increase IL-1β production in macrophages5.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [5] Rubic, T. et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9, 1261–1269 (2008). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As such, following ischemia/hypoxia, or when SDH operation is affected by genetic aberrations (such a tumors harboring SDH mutations) elevated succinate can potentiate the hypoxic phenotype by leading to further HIF-1α stabilization.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“DI was shown to significantly and acutely deplete GSH levels, confirming it was indeed an activated Michael acceptor59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Lampropoulou and colleagues (2016) reported an upregulation of genes involved in Phase II conjugation, glutathione conjugation and biological oxidations from an RNA-seq screen performed in DI-treated BMDMs50.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an endogenous inhibitor of SDH and an anti-inflammatory metabolite
What the sources say
- Not checked yetcites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Importantly, Lampropoulou and colleagues (2016) first demonstrated that bone-marrow derived macrophages (BMDMs) activated by LPS and pre-treated with a cell permeable methyl ester derivative of itaconate, dimethyl itaconate (DI), exhibited potent inhibition of pro-inflammatory mediators including nitic oxide (NO), ROS and the cytokines IL-6, IL-12p70 and IL-1β13,50.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an endogenous inhibitor of SDH and an anti-inflammatory metabolite
What the sources say
- Not checked yetcites [13] van Diepen, J. A. et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia 60, 1304–1313 (2017). source
- Not checked yetcites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“ROS production in this setting is believed to be as a result of reverse electron transport (RET) at complex I of the electron transport chain.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this way succinate, and α-KG, can remodel the epigenome.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between succinate, the epigenome and innate immune memory
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A critical consequence of succinate elevation in response to LPS is the potentiation of inflammatory signalling and in particular IL-1β, in a HIF-1α-dependent manner2.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The finding that hypoxia was capable of inducing IL-1β production in astrocytes in an NF-κB-independent, HIF-1α-dependent, mechanism 28 led to the discovery of a HRE in the IL-1β promoter 2.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
- Not checked yetcites [28] Rasola, A., Neckers, L. & Picard, D. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells. Trends Cell Biol. 24, 455–463 (2014). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“itaconate and 4-OI were shown to have a similar thiol reactivity profile”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“At a molecular level this involves epigenetic modifications, leading to stronger gene transcription upon re-stimulation, as opposed to gene recombination that occurs in the adaptive memory response.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between succinate, the epigenome and innate immune memory
What the sources say
- Not checked yetcites [35] Peyssonnaux, C. et al. Cutting edge: essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J. Immunol. 178, 7516–7519 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inhibition of HIF-1α with ascorbate impaired the training effect induced by β-glucan and decreased TNF-α production in these cells, demonstrating a requirement for HIF-1α in the training effect induced by β-glucan.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between succinate, the epigenome and innate immune memory
What the sources say
- Not checked yetcites [37] El-Khoury, R. et al. Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives. Br. J. Pharmacol. 171, 2243–2249 (2014). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“It should be noted that hypoxia and ischemia, as well as decreased oxidative phosphorylation, drive succinate accumulation in the mitochondrial matrix26,27.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [26] Wu, W. & Zhao, S. Metabolic changes in cancer: beyond the Warburg effect. Acta Biochim. Biophys. Sin. (Shanghai) 45, 18–26 (2013). source
- Not checked yetcites [27] Selak, M. A. et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell. 7, 77–85 (2005). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“α-KG and succinate can regulate the activity of other members of the α-KGDD family of enzymes, in particular those involved in the regulation of histone and DNA demethylation, the α-KG-dependent Jumonji C-domain containing histone demethylases (JMJDs) and the Ten eleven translocation (TET) family of 5mC hydroxylases, which play a role in DNA demethylation.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between succinate, the epigenome and innate immune memory
What the sources say
- Not checked yetcites [33] Chouchani, E. T. et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515, 431–435 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“However, it must also be noted that, compared with malonate, itaconate is a relatively weak competitive inhibitor of SDH47,49, which raised the question as to whether any additional mechanisms could contribute to the anti-inflammatory effects of itaconate.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an endogenous inhibitor of SDH and an anti-inflammatory metabolite
What the sources say
- Not checked yetcites [47] Xie, L. et al. First succinyl-proteome profiling of extensively drug-resistant Mycobacterium tuberculosis revealed involvement of succinylation in cellular physiology. J. Proteome Res. 14, 107–119 (2015). source
- Not checked yetcites [49] He, D. et al. Global proteome analyses of lysine acetylation and succinylation reveal the widespread involvement of both modification in metabolism in the embryo of germinating rice seed. J. Proteome Res. 15, 879–890 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“this effect was independent of its ability to act as an anti-bactericidal agent73.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [73] Brennan, M. S. et al. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS One 10, e0120254 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Further supporting the hypothesis that itaconate was a thiol reactive metabolite, a significant increase in the levels of the metabolite 2,3-dicarboxypropyl cysteine (itaconate-cysteine adduct), akin to (S)-2-succinocysteine (2SC) a breakdown product of fumarate-mediated protein succination, was observed in LPS-activated BMDMs59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“no differences were observed in IκBξ levels between Irg1-/- and wildtype macrophages stimulated with LPS60.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These data suggest that itaconate may dampen the immune response of Mtb-infected mice to limit immunopathology.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“an effect shown to be mediated through inhibition of IκBξ the major transcription factor governing secondary transcriptional responses to TLR activation60.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“1EI (an activated Michael acceptor) could also inhibit IκBξ”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“an effect that was at least partially dependent on Nrf259.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Bambouskova and colleagues (2018) demonstrated that DI could induce electrophilic stress and Nrf2 in macrophages via depletion of intracellular GSH to form a DI-GSH adduct”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“IRG1 suppresses the production of the pro-inflammatory cytokines TNF-α, IL-6 and IFN-β in LPS-tolerised BMDMs67.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [67] Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the IκBξ–ATF3 inflammatory axis. Nature 556, 501–504 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“an effect thought to be a consequence of itaconate-mediated transcriptional regulation of the inflammatory response73.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [73] Brennan, M. S. et al. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS One 10, e0120254 (2015). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Irg1 was shown to specifically impair neutrophil recruitment to the lungs to curtail excessive lung inflammation and pathology”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [73] Brennan, M. S. et al. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS One 10, e0120254 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“4-OI was shown to alkylate KEAP1 on several cysteine residues, namely cysteine 151 (C151), a principal redox sensing cysteine important for activation of Nrf259,66.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
- Not checked yetcites [66] Williams, J. O., Roche, T. E. & McFadden, B. A. Mechanism of action of isocitrate lyase from Pseudomonas indigofera. Biochemistry 10, 1384–1390 (1971). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“the induction of Irg1 and itaconate was largely dependent on autocrine/paracrine type I interferon signalling59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Bambouskova and colleagues (2018) who demonstrated a decrease in LPS-induced Nrf2 stabilisation in Irg1-deficient BMDMs”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“it also appears to play a major role in embryo implantation in the womb, a process thought to require immunosuppression70–72.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [70] Ackermann, W. W. & Potter, V. R. Enzyme inhibition in relation to chemotherapy. Proc. Soc. Exp. Biol. Med. 72, 1–9 (1949). source
- Not checked yetcites [71] El Azzouny, M. et al. Dimethyl itaconate is not metabolized into itaconate intracellularly. J. Biol. Chem. 292, 4766–4769 (2017). source
- Not checked yetcites [72] Kobayashi, E. H. et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat. Commun. 7, 11624 (2016). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“the ability of 4-OI to induce NQO1 activity remained unaffected59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the profound levels to which it is produced in macrophages suggest that it is likely to be central to macrophage function.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“4EI (which has similar reactivity to endogenous itaconate) could not inhibit IκBξ unless GSH synthesis was inhibited by buthionine sulfoximine (BSO)60.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Furthermore, using a quantitative unbiased proteomic screen performed in both LPS (which will drive intracellular itaconate accumulation) and 4-OI-treated macrophages, several metabolic and inflammatory proteins were found to be alkylated representing the first demonstration of this novel post-translational modification (PTM), termed 2,3-dicarboxypropylation59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“pre-treatment of LPS-activated macrophages with 4-OI resulted in a significant attenuation of IFN-β levels and interferon-stimulated genes (ISGs), namely ISG20”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Pre-treatment of LPS-activated BMDMs with 4-OI also resulted in a significant attenuation of IL-1β levels”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“confirming that endogenous itaconate stabilizes Nrf260.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“an effect that was largely abrogated in Nrf2-deficent macrophages59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“IRG1 was also found to be significantly increased in A20-deficient macrophages”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [68] Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113–117 (2018). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Nair and colleagues (2018) convincingly demonstrated an increase in pro-inflammatory cytokine production, including IL-6 and IL-1β, in Mtb-infected Irg1-deficent mice”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [73] Brennan, M. S. et al. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS One 10, e0120254 (2015). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Yingke and colleagues (2013) also observed increased IFN-β and IRF3 signaling in LPS-tolerized Irg1-silenced macrophages”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [67] Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the IκBξ–ATF3 inflammatory axis. Nature 556, 501–504 (2018). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Nrf2 can also limit LPS-induced inflammatory gene transcription, in a redox-independent manner, through direct ligation of these genes and inhibition of RNA polymerse II recruitment47.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [47] Xie, L. et al. First succinyl-proteome profiling of extensively drug-resistant Mycobacterium tuberculosis revealed involvement of succinylation in cellular physiology. J. Proteome Res. 14, 107–119 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Yingke and colleagues (2013) attributed the effect of IRG1 on cytokine production to ROS-mediated induction of A20”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [67] Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the IκBξ–ATF3 inflammatory axis. Nature 556, 501–504 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“pre-treatment of control and LPS-activated macrophages with 4-OI still resulted in a significant increase in Nrf2 and Nrf2 target genes, namely Heme oxygenase 1 (HMOX1)”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“the ability of DI to induce NQO1 activity (a prototypical Nrf2 target gene) was diminished when pre-incubated with GSH”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“it is unlikely to have any physiological relevance to this canonical pathway.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“To determine the role of increased fumarate levels on the epigenetic landscape, Arts and colleagues (2016) used the cell permeable fumaric acid ester, monomethyl fumarate (MMF), which was shown to alter histone methylation with similarities to β-glucan induced training97.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [97] Rustin, P. et al. Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim. Biophys. Acta 1361, 185–197 (1997). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The first insights into the relevance of succination in HRLCC patients was proposed in 2011, when it was shown that fumarate could bind reactive thiol residues and inactivate KEAP1, the negative regulator of the master antioxidant transcription factor Nrf2, leading to a powerful antioxidant response81,82”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [81] Weiss, J. M. et al. Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors. J. Clin. Invest. 128, 3794–3805 (2018). source
- Not checked yetcites [82] Hall, C. J. et al. Immunoresponsive gene 1 augments bactericidal activity of macrophage-lineage cells by regulating β-oxidation-dependent mitochondrial ROS production. Cell. Metab. 18, 265–278 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Furthermore, Weiss and colleagues (2018) demonstrated that ROS production in response to itaconate regulates Nrf2”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
What the sources say
- Not checked yetcites [75] Li, Y. et al. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J. Biol. Chem. 288, 16225–16234 (2013). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Furthermore, IRG1 (and presumably itaconate) levels were also shown to be markedly increased in glioma tissue75.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
What the sources say
- Not checked yetcites [75] Li, Y. et al. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J. Biol. Chem. 288, 16225–16234 (2013). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“However, in 2002 it was shown that mutations of FH are the cause of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), a cancer predisposition syndrome characterised by benign tumours of the smooth muscle of skin and uterus, and a very aggressive form of renal cancer78.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [78] Cheon, Y. P., Xu, X., Bagchi, M. K. & Bagchi, I. C. Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse. Endocrinology 144, 5623–5630 (2003). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Outside of trained immunity, fumarate has previously been reported to accumulate in LPS-activated macrophages1,13.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [1] Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015). source
- Not checked yetcites [13] van Diepen, J. A. et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia 60, 1304–1313 (2017). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Furthermore, treatment with MMF augmented TNF and IL-6 secretion in β-glucan-trained macrophages stimulated with LPS97.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [97] Rustin, P. et al. Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim. Biophys. Acta 1361, 185–197 (1997). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Importantly, Arts and colleagues (2016) demonstrated that the accumulation of fumarate in β-glucan-treated monocytes was essential for trained immunity by enhancing cytokine production upon re-stimulation with LPS97.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [97] Rustin, P. et al. Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim. Biophys. Acta 1361, 185–197 (1997). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“For instance, accumulated fumarate can bind and inactivate reactive thiol residues of proteins and peptides in a process called succination, a protein modification originally described in diabetes80.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [80] Sherwin, J. R. et al. Identification of genes regulated by leukemia-inhibitory factor in the mouse uterus at the time of implantation. Mol. Endocrinol. 18, 2185–2195 (2004). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Itaconate was shown to boost OXPHOS and mtROS generation and subsequent MAPK activation in tumour-infiltrating macrophages (Figure 3).”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
What the sources say
- Not checked yetcites [74] Saito, R. et al. Characterizations of three major cysteine sensors of Keap1 in stress response. Mol. Cell Biol. 36, 271–284 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“By employing a proteomic approach the authors discovered a range of proteins which regulate T cell function that are sensitive to covalent modification by DMF including protein kinase C θ (PKCθ).”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [49] He, D. et al. Global proteome analyses of lysine acetylation and succinylation reveal the widespread involvement of both modification in metabolism in the embryo of germinating rice seed. J. Proteome Res. 15, 879–890 (2016). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The defining biochemical feature of FH loss is the accumulation of fumarate, which has been implicated in tumorigenesis, acting as an oncometabolite79.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [79] Luan, H. H. & Medzhitov, R. Food fight: role of itaconate and other metabolites in antimicrobial defense. Cell. Metab. 24, 379–387 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Using an integrated high-throughput transcriptional metabolic profiling and analysis pipeline (CoMBI-T), Jha and colleagues (2015) described the induction of an inflammatory argininosuccinate shunt, a metabolic pathway that links the Krebs cycle to the Urea cycle1.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [1] Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Importantly, inhibition of aerobic glycolysis by the specific GAPDH inhibitor heptelidic acid (HA) and 2-deoxyglucose (2-DG) recapitulated the immunomodulatory effects of DMF in vitro, while in vivo administration of HA inhibited the development of experimental autoimmune encephalomyelitis (EAE), a murine model of MS99.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As such, itaconate serves as another example of crosstalk between macrophages and tumours in the context of metabolic reprogramming.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Two pro-inflammatory T cell subsets implicated in the pathogenesis of MS, namely TH1 and TH17 cells, rely heavily on aerobic glycolysis and treatment with DMF or MMF inhibited their development in vitro, as previously reported99,101,102, 49.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
- Not checked yetcites [101] Ooi, A. et al. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 20, 511–523 (2011). source
- Not checked yetcites [102] Sullivan, L. B. et al. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol. Cell 51, 236–248 (2013). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Two pro-inflammatory T cell subsets implicated in the pathogenesis of MS, namely TH1 and TH17 cells, rely heavily on aerobic glycolysis and treatment with DMF or MMF inhibited their development in vitro, as previously reported99,101,102, 49.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
- Not checked yetcites [101] Ooi, A. et al. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 20, 511–523 (2011). source
- Not checked yetcites [102] Sullivan, L. B. et al. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol. Cell 51, 236–248 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Intriguingly, endogenous fumarate was also found to succinate GAPDH in both mouse and human macrophages, suggesting that elevated fumarate levels may act as an endogenous anti-inflammatory signal to limit inflammation, however, the precise role of fumarate accumulation remains an open question to be explored.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Furthermore, increased fumarate levels were shown to be driven by enhanced shunting of glutamine into the TCA cycle, otherwise referred to as glutamine anaplerosis, as ascertained by a combination of biochemical techniques and the use of the glutaminase inhibitor, BPTES97.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [97] Rustin, P. et al. Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim. Biophys. Acta 1361, 185–197 (1997). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Induction of this pathway occurred via an increase in the expression of argininosuccinate synthase (Ass1), which catalyses the formation of argininosuccinate from aspartate, citrulline and ATP98.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [1] Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Succination is a hallmark of FH-deficient tumours and an antibody against succinate protein has been proposed as a diagnostic marker for HLRCC89.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [89] Delage, B. et al. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int. J. Cancer 126, 2762–2772 (2010). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“It has also recently been shown that FH loss in renal cancer cells leads to increased DNA damage and resistance to ionising radiation (IR), due to a fumarate-dependent inhibition of mitotic entry after IR, even in the presence of unrepaired damage179.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [179] Zhang, J. et al. accumulation of succinate in cardiac ischemia primarily occurs via canonical Krebs cycle activity. Cell Rep. 23, 2617–2628 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Of note, fumarate-dependent oxidative stress was shown to drive renal cells to senescence in an FH-deficient mouse model, and its bypass by the co-ablation of p21 increased malignant transformation in the kidneys503.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [503]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In addition to CD4+ T cells, an unexpected role for L-2-HG in the promotion of tumour killing acting via CD8+ T cells, cytotoxic T lymphocytes important for anti-tumour immunity, has emerged149.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Accordingly, fumarate causes HIF stabilisation, even under normoxic conditions, i.e. pseudohypoxia, a hallmark of FH-deficient tumours93.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [93] Brück, J., Dringen, R., Amasuno, A., Pau-Charles, I. & Ghoreschi, K. A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis. Exp. Dermatol. 27, 611–624 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A third 2HGA that arises from germline mutations in the mitochondrial citrate carrier SLC25A1, in which both enantiomers accumulate, has also been discovered.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer
What the sources say
- Not checked yetcites [111] Yang, M., Soga, T., Pollard, P. J. & Adam, J. The emerging role of fumarate as an oncometabolite. Front. Oncol. 2, 85 (2012). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Of note, fumarate-dependent oxidative stress was shown to drive renal cells to senescence in an FH-deficient mouse model, and its bypass by the co-ablation of p21 increased malignant transformation in the kidneys503.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [503]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Mechanistically, D-2-HG production was driven by the conversion of glutamate to α-KG by the aspartate aminotransferase GOT1.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Of note, FH-deficient renal cancers are characterised by a distinct DNA hypermethylation phenotype, which also affects the tumour suppressor CDK2NA85”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [85] Frezza, C. Mitochondrial metabolites: undercover signalling molecules. Interface Focus 7, 20160100 (2017). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“and also iron-responsive element binding protein (IRP)2, promting the transcription of transferrin87.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [87] Tomlinson, I. P. et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genet. 30, 406–410 (2002). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Succination is a hallmark of FH-deficient tumours and an antibody against succinate protein has been proposed as a diagnostic marker for HLRCC89.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [89] Delage, B. et al. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int. J. Cancer 126, 2762–2772 (2010). source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In recent years, two landmark genomic studies carried out in human glioma and acute myeloid leukaemia (AML) found mutations in IDH1/2 and it is now appreciated that these enzymes (which drive elevated production of D-2-HG) are the most frequently mutated metabolic genes in human cancer112-114.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer
What the sources say
- Not checked yetcites [112] Sciacovelli, M. et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature 537, 544–547 (2016). source
- Not checked yetcites [113] Brabletz, T., Kalluri, R., Nieto, M. A. & Weinberg, R. A. EMT in cancer. Nat. Rev. Cancer 18, 128–134 (2018). source
- Not checked yetcites [114] Brat, D. J. et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372, 2481–2498 (2015). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Interestingly, Xu and colleagues (2017) observed increased levels in of D-2-HG in TH17 cells, when compared to iTreg cells143.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“It has also been shown that fumarate accumulation leads to the inhibition of TET-dependent DNA demethylation of a class of antimetastatic miRNAs, the miR200 family, promoting an EMT95”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [95] Zheng, L. et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat. Commun. 6, 6001 (2015). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Fumarate was shown to cause succination of the mitochondrial aconitase, ACO2, leading to an additional truncation of the TCA cycle86”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [86] Arts, R. J. et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell. Metab. 24, 807–819 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“On the other hand, induced regulatory T (iTreg) cells, also derived from naïve CD4+ T cells, do not require HIF-1α143,146.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
- Not checked yetcites [146] Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 17, 510–522 (2010). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In IDH1/2-mutant gliomas, D-2-HG has been reported to accumulate to levels up to 35 mM, as such, D-2-HG could inhibit α-KG-dependent dioxygenases to affect alternative cellular signaling pathways120.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [120] Chalmers, R. A. et al. d-2-hydroxyglutaric aciduria: case report and biochemical studies. J. Inherit. Metab. Dis. 3, 11–15 (1980). source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Furthermore, exogenous treatment of CD8+ T cells with L-2-HG greatly enhanced the in vivo proliferation, persistence and anti-tumour capacity of adoptively transferred CD8+ T cells149.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Functionally, L-2HG is both sufficient to try histone methylation, in particular histone 3 lysine 9 (H3K9me3), and can also promote HIF-1α stabilization in normoxia and therefore may assist with hypoxic adaptation.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Although the IC50 of D-2-HG toward KDM family members is in the low micromolar range (24-106 μM), it can also inhibit FIH and PHD2, with IC50 values of 1.5 and 7.3 mM, respectively121.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Accumulation of L-2-HG altered CD8+ T cell differentiation through modulation of both the histone and DNA methylation landscape of the cell, and also via HIF stability149.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“another possible mechanism by which D-2-HG drives tumorigenesis is through the promotion of genetic instability, predisposing cells to oncogenic transformation103.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [103] Linehan, W. M. et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med. 374, 135–145 (2016). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The most commonly occurring cancers thought to arise from mutant IDH1/2 (mIDH1/2) include glioma, cartilaginous tumours, AML, angioimmunoblastic T cell lymphoma (AITL) and intrahepatic cholangiocarcinoma (ICC).”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [103] Linehan, W. M. et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med. 374, 135–145 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“D-2-HG has been shown to inhibit α-KG-dependent alkylation repair homologs, ALKBH2 and ALKBH3, critical DNA damage repair enzymes that detoxify 1-methyladenine (1 mA) and 3-methlycytosine (3mC) lesions in DNA derived from alkylating agents121,131.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
- Not checked yetcites [131] MacIver, N. J., Michalek, R. D. & Rathmell, J. C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31, 259–283 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“D-2-HG produced by mIDH1 in low grade glioma was found to activate mechanistic target of rapamycin (mTOR) signaling133.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [133] Xu, T. et al. Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature 548, 228–233 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Mechanistically, it was proposed that D-2-HG destabilised DEPTOR, a negative regulator of mTORC1/2 partly through inhibition of the histone demethylase KDM4A133.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [133] Xu, T. et al. Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature 548, 228–233 (2017). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Indeed, D-2-HG accumulation in IDH-mutant glioma has been found to inhibit PHD hydroxylase and stabilise HIF-1α126 and HIF-1αstabilisation has been shown to occur in IDH1-mutant brain tissue127.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [127] Nota, B. et al. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined d-2- and l-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 92, 627–631 (2013). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“metabolomic profiling of mIDH1/2 gliomas revealed significant alterations in cellular metabolism, an effect recapitulated with the exogenous addition of D-2-HG134.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [134] Figueroa, M. E. et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 18, 553–567 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“As with succinate and fumarate, D-2-HG acts as a competitive inhibitor of α-KGDDs including, but not limited to, the TET family and JMJD family of DNA and histone demethylases, respectively121,22.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
- Not checked yetcites [22] Epstein, A. C. R. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54 (2001). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“L-2HG is also a potent inhibitor of α-KG-dependent enzymes.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [51] Du, J. et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806–809 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Interestingly, Tyrakis and colleagues (2016) observed a dramatic increase in L-2-HG levels, reaching up to 1.5 mM, in response to T-cell receptor triggering in mouse CD8+ T cells149.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“It was shown that during adipocyte differentiation, global histone acetylation is determined by glucose availability through an ACL-dependent pathway 54.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation
What the sources say
- Not checked yetcites [54] Wang, F. et al. SIRT5 desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1β production and to prevent dss-induced colitis in mice. Cell Rep. 19, 2331–2344 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“An unbiased mass spectrometry-based study of the nuclear phosphoproteome of resting and IL-2-treated CD4+ T-lymphocytes revealed that ACLY is phosphorylated in response to IL-2 treatment 57.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA and histone acetylation regulate of immune cell function
What the sources say
- Not checked yetcites [57] Meiser, J. et al. Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J. Biol. Chem. 291, 3932–3946 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Multiple mechanisms involving acetyl-CoA may therefore exist to regulate Ifng expression.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA and histone acetylation regulate of immune cell function
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These data suggest that histone acetylation levels might be a valuable biomarker to predict tumor relapse.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA alters the epigenome of tumor cells
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“histone acetylation and phosphorylated Akt levels correlate significantly in human glioma and human prostate cancer”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA alters the epigenome of tumor cells
What the sources say
- Not checked yetcites [58] Németh, B. et al. Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage. FASEB J. 30, 286–300 (2016). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inhibiting the mitochondrial enzyme SDH during ischaemia by preloading tissues with the SDH inhibitor DMM prevented succinate accumulation during ischaemia and protected against tissue damage upon reperfusion150.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [150] Zhao, S. et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1α. Science 324, 261–265 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As such, the initiation and pathogenesis of IDH-mutant tumours may share parallels with SDH-mutant tumours.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“succinate accumulated during ischaemia and is then oxidised upon reperfusion to drive the mitochondrial superoxide formation that contributes to ischaemia-reperfusion (IR) injury150,151.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [150] Zhao, S. et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1α. Science 324, 261–265 (2009). source
- Not checked yetcites [151] Intlekofer, A. M. et al. Hypoxia induces production of l-2-hydroxyglutarate. Cell Metab. 22, 304–311 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The authors demonstrate that LDA, an enzyme that catalyzes the reversible conversion of pyruvate and NADH to lactate and NAD+, is induced in activated T cells and enhances histone acetylation of interferon gamma (Ifng) via the maintenance of acetyl-CoA levels to promote its expression 55.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA and histone acetylation regulate of immune cell function
What the sources say
- Not checked yetcites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“a portion of the succinate that accumulates during ischemia and inflammation is released from the cell into the extracellular environment through poorly defined processes. This occurs following IR injury158,159, inflammation10, or cold exposure160.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [158] Carbonneau, M. et al. The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Nat. Commun. 7, 12700 (2016). source
- Not checked yetcites [159] Reitman, Z. J. et al. Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc. Natl. Acad. Sci. USA 108, 3270–3275 (2011). source
- Not checked yetcites [10] Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014). source
- Not checked yetcites [160] Chesnelong, C. et al. Lactate dehydrogenase A silencing in IDH mutant gliomas. Neuro-Oncol. 16, 686–695 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“all suggesting that cellular reprogramming elicited by D-2-HG may play a prominent role in the pathogenesis of IDH-mutant tumours135-137.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [135] Losman, J. A. et al. R-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339, 1621–1625 (2013). source
- Not checked yetcites [136] Tyrakis, P. A. et al. S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. Nature 540, 236–241 (2016). source
- Not checked yetcites [137] Doedens, A. L. et al. Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen. Nat. Immunol. 14, 1173–1182 (2013). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“one likely role is as an inflammatory signal, acting via SUCNR14,5,161,162.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
- Not checked yetcites [5] Rubic, T. et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9, 1261–1269 (2008). source
- Not checked yetcites [161] Grassian, A. R. et al. IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. Cancer Res. 74, 3317–3331 (2014). source
- Not checked yetcites [162] Izquierdo-Garcia, J. L. et al. IDH1 mutation induces reprogramming of pyruvate metabolism. Cancer Res. 75, 2999–3009 (2015). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“These findings therefore suggest that both suppression of RIP3-mediated necroptosis and MLK3-mediated apoptosis by D-2-HG may contribute to IDH-mutant carcinogenesis140,141.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [140] Watanabe, T., Nobusawa, S., Kleihues, P. & Ohgaki, H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am. J. Pathol. 174, 1149–1153 (2009). source
- Not checked yetcites [141] Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Pharmacological or genetic ablation of ACLY function impaired IL-2-promoted T-cell growth.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA and histone acetylation regulate of immune cell function
What the sources say
- Not checked yetcites [57] Meiser, J. et al. Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J. Biol. Chem. 291, 3932–3946 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In 2014 Lee and colleagues demonstrated that acetyl-CoA levels and histone acetylation in tumors are regulated by oncogenic activation of Akt and subsequent ACLY phosphorylation58.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA alters the epigenome of tumor cells
What the sources say
- Not checked yetcites [58] Németh, B. et al. Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage. FASEB J. 30, 286–300 (2016). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“levels of histone acetylation have been shown to be predictive of which patients would later exhibit biochemical failure, with lower levels predictive of worse outcome.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA alters the epigenome of tumor cells
What the sources say
- Not checked yetcites [58] Németh, B. et al. Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage. FASEB J. 30, 286–300 (2016). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hence, simple molecules designed to inhibit SDH are a novel class of anti-inflammatory and anti-IR injury compounds.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Malonate itself was also protective when added at reperfusion152,153.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [152] Intlekofer, A. M. et al. l-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH. Nat. Chem. Biol. 13, 494–500 (2017). source
- Not checked yetcites [153] Nadtochiy, S. M. et al. Acidic pH Is a metabolic switch for 2-hydroxyglutarate generation and signaling. J. Biol. Chem. 291, 20188–20197 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Cells depleted of ACL contained visibly less lipid than control cells.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation
What the sources say
- Not checked yetcites [54] Wang, F. et al. SIRT5 desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1β production and to prevent dss-induced colitis in mice. Cell Rep. 19, 2331–2344 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“ACLY, acetyl-CoA levels and histone acetylation have also been shown to play an important role in the DNA damage response in tumor cells 59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA alters the epigenome of tumor cells
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This work indicated that simple inhibitors of Krebs cycle enzymes could be used to prevent pathological damage.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The generation of itaconate from the Krebs Cycle intermediate cis-aconitate contrasts with most other metabolite signals emanating from mitochondria, in that it primarily acts as a protective, anti-inflammatory metabolite55,59,60.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The therapeutic potential of DI was also demonstrated as in vivo administration of DI resulted in an amelioration of skin pathology in a mouse model of psoriasis, a disease also currently treated by the related electrophile DMF60,65.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
- Not checked yetcites [65] Naujoks, J. et al. IFNs modify the proteome of Legionella-containing vacuoles and restrict infection via IRG1-derived itaconic acid. PLoS Pathog. 12, e1005408 (2016). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“the emerging role of Krebs cycle intermediates in many central biomedical pathways opens up the possibility of extending mitochondrial pharmacology164-167 to manipulating the levels and impacts of mitochondrial metabolites both within the matrix, the rest of the cell, or following their release from the cell into the circulation.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [164] Li, F. et al. NADP+–IDH mutations promote hypersuccinylation that impairs mitochondria respiration and induces apoptosis resistance. Mol. Cell 60, 661–675 (2015). source
- Not checked yetcites [165] Jiang, B. et al. IDH1 mutation promotes tumorigenesis by inhibiting JNK activation and apoptosis induced by serum starvation. Cell Rep. 19, 389–400 (2017). source
- Not checked yetcites [166] Yang, Z. et al. 2-HG inhibits necroptosis by stimulating DNMT1-dependent hypermethylation of the RIP3 promoter. Cell Rep. 19, 1846–1857 (2017). source
- Not checked yetcites [167] Kurdistani, S. K. & Grunstein, M. Histone acetylation and deacetylation in yeast. Nat. Rev. Mol. Cell Biol. 4, 276–284 (2003). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 98
- Probably not a substantial claim. 7
Every source the paper cites for this claim was checked and supports it.
In the paper
“The sustained induction of IL-1β in response to LPS was shown to require HIF-1α and to occur under normoxia.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Supportedcites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
In the indexed paper’s section labeled Abstract (page unavailable), HIF-1α binds the Il1b promoter in LPS-stimulated macrophages at 4, 12, and 24 hours, and IL-1β induction is attenuated in HIF-1α-deficient macrophages. The paper describes LPS-induced HIF-1α stabilization as pseudohypoxia and reports aerobic glycolysis, supporting induction without hypoxic conditions. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Recent data demonstrated that fumarate acts as a powerful inhibitor of the TET family of DNA demethylases and of a series of histone demethylases91,92.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Could not verifycites [91] Angiari, S. & O’Neill, L. A. Dimethyl fumarate: targeting glycolysis to treat MS. Cell Res. 28, 613–615 (2018). sourceExperimental — accuracy not yet measured
The paper’s discussion of fumarate and succination (section “Dimethyl fumarate: targeting glycolysis to treat MS,” page not identified in our copy) concerns GAPDH inhibition. Searches for TET-family DNA demethylases and histone demethylases found no passage addressing whether fumarate inhibits either group. (LLM, conf=0.76)
- Could not verifycites [92] Kornberg, M. D. et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360, 449–453 (2018). sourceExperimental — accuracy not yet measured
The paper’s Abstract discusses fumarate and dimethyl fumarate modifying proteins, particularly GAPDH, but does not address inhibition of TET DNA demethylases or histone demethylases. Searches for those enzymes and for epigenetic demethylation found no passage supporting the attributed claim. (LLM, conf=0.72)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The authors demonstrate that ACLY is required to enhance histone acetylation levels and induce the expression of cell cycle regulating genes in response to IL-2.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA and histone acetylation regulate of immune cell function
What the sources say
- Could not verifycites [57] Meiser, J. et al. Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J. Biol. Chem. 291, 3932–3946 (2016). sourceExperimental — accuracy not yet measured
The Introduction and Results discuss PDH flux and LPS-activated macrophages, not IL-2 responses or histone acetylation. A search for ACLY and ATP-dependent citrate lyase found a Discussion passage about oxaloacetate production, but no passage addressing whether ACLY is required for histone acetylation or cell-cycle gene expression. Page numbers were not available in our copy. (LLM, conf=0.76)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“High levels of succinate or 2-HG inhibit α-KGDDs. These include the PHDs, the TET DNA demethylases, and the JMJDs154-156”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
- Not checked yetcites [61] Shin, J. H. et al. 1H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J. Proteome Res. 10, 2238–2247 (2011). source
- Not checked yetcites [62] Sugimoto, M. S. H. Y. et al. Non-targeted metabolite profiling in activated macrophage secretion. Metabolomics 8, 624–633 (2011). source
- Partly supportedcites [154] Sasaki, M. et al. d-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function. Genes Dev. 26, 2038–2049 (2012). sourceExperimental — accuracy not yet measured
The passages labeled Abstract identify TET enzymes and Jumonji-domain histone demethylases as possible D2HG targets and state that succinate inhibits PHDs. The ROS section reports evidence consistent with D2HG inhibition of TET enzymes and says the authors concur that it blocks PHD-mediated modification, but it also notes conflicting PHD findings and no change in histone methylation in their cells. The copy does not establish that succinate inhibits TET enzymes or JMJDs, so the claim's unqualified grouping overstates the evidence. (LLM, conf=0.83)
- Partly supportedcites [155] Tarhonskaya, H. et al. Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases. Nat. Commun. 5, 3423 (2014). sourceExperimental — accuracy not yet measured
The introduction (page unavailable) says elevated succinate and 2-HG are proposed to inhibit 2-oxoglutarate oxygenases. The paper reports 2-HG inhibition of a JmjC demethylase, but treats inhibition of TET enzymes as possible and finds that 2-HG is only a weak inhibitor of PHD2. The claim presents inhibition across all three enzyme groups more definitively than the source does. (LLM, conf=0.85)
- Partly supportedcites [156] Wang, P. et al. Oncometabolite d-2-hydroxyglutarate inhibits ALKBH DNA repair enzymes and sensitizes IDH mutant cells to alkylating agents. Cell Rep. 13, 2353–2361 (2015). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says D-2-HG inhibits α-KG-dependent dioxygenases, including JmjC histone demethylases and TET DNA hydroxylases. Our copy does not support the additional claims that succinate inhibits these enzymes or that PHDs are among the inhibited enzymes; searches for succinate and PHDs/prolyl hydroxylases found no relevant passage. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“HIF-1 binds to hypoxia response elements (HREs) in target genes and increases the expression of numerous glycolytic enzymes and the glucose transporters (GLUT)1 and GLUT3.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Analogous to tumours, LPS-induced succinate was shown to both directly and indirectly (via ROS) inhibit PHD activity in macrophages resulting in stabilization of HIF-1α2.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“An additional mechanism by which succinate accumulates tumors involves the mitochondrial chaperone, tumor necrosis factor receptor-associated protein 1 (TRAP1) which is highly expressed in many tumors22. TRAP1 decreases SDH activity and succinate accumulates as a result.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [22] Epstein, A. C. R. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54 (2001). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In the presence of oxygen, conserved proline residues in the HIF-1α subunit are hydroxylated by PHD 1, 2 and 3 16. Hydroxylation provides a recognition site for the binding of Von Hippel-Lindau (VHL) E3 ubiquitin ligase, which ubiquitinates HIF-1α and subsequently targets it for proteasomal degradation17.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [16] Peruzzotti-Jametti, L. et al. Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation. Cell Stem Cell 22, 355–368.e13 (2018). source
- Not checked yetcites [17] Bhuniya, D. et al. Discovery of a potent and selective small molecule hGPR91 antagonist. Bioorg. Med. Chem. Lett. 21, 3596–3602 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“SUCNR1 is highly expressed in mouse kidney, liver, spleen, small intestine3, and on dendritic cells (DCs) 4 and ligand binding induces Gi and Gq signalling cascades3.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [3] He, W. et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429, 188–193 (2004). source
- Not checked yetcites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Extracellular succinate addition also acts in synergy with TLR ligands to increase TNFα and IL-1β expression4 and increases the capacity of DCs to act as antigen presenting cells.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [4] Chouchani, E. T. et al. A unifying mechanism for mitochondrial superoxide production during ischemia–reperfusion injury. Cell. Metab. 23, 254–263 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Specifically, succinate is elevated in plasma after acute exercise and in marathon runners175.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [175] Sivanand, S. et al. Nuclear acetyl-CoA production by ACLY promotes homologous recombination. Mol. Cell 67, 252–265.e56 (2017). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“succinate has been shown to act through several pathways to exert its inflammatory effects: through direct generation of mitochondrial ROS (mtROS), by activation of hypoxia-inducible factor-1alpha (HIF-1α; discussed below), and by through ligation of the G-protein coupled receptor succinate receptor 1 (SUCNR1).”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In a mouse model of multiple sclerosis (MS) transplantation of neural stem cells (NSCs) reduced succinate levels in the cerebrospinal fluid and thereby decreased infiltration of damaging macrophages and microglial cells10.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [10] Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“He and colleagues made an important discovery when they found that the Krebs cycle-derived metabolites, succinate and α-KG, acted as ligands for the orphan G-protein coupled receptors GPR91 (now known as SUCNR1) and GPR99 (now known as OXRG1), respectively3.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [3] He, W. et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429, 188–193 (2004). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This degradation is prevented in conditions of limited oxygen, allowing for HIF-1α translocation to the nucleus, dimerization with HIF-1β and binding of target genes13.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [13] van Diepen, J. A. et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia 60, 1304–1313 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The authors demonstrated that succinate acted as an important hypertensive agent, modulating the renin-angiotensin system via SUCNR1 signalling, independent of its role in bioenergetics3.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [3] He, W. et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429, 188–193 (2004). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“ROS also impair the activity of Factor Inhibiting HIF (FIH), another member of the α-KGDD family25, which hydroxylates an asparagine residue in the carboxy terminal of HIF-1α resulting in a decrease in transcriptional activity.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [25] Frede, S., Stockmann, C., Freitag, P. & Fandrey, J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB. Biochem. J. 396, 517–527 (2006). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Recent data indicate that succinate is a pro-inflammatory metabolite that accumulates in LPS/IFN-γ-treated macrophages1,2.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells
What the sources say
- Not checked yetcites [1] Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015). source
- Not checked yetcites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mechanistically, ligation of SUCNR1 on the surface of NSCs upregulates the expression of the dicarboxylate co-transporter Slc13a3/5, which correlates with increased uptake by the NSCs thereby scavenging succinate away from pro-inflammatory immune cells.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [10] Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“ROS-can stabilize HIF-1α by inducing non-enzymatic decarboxylation of α-KG24 and by oxidizing iron (Fe2+) to Fe3+, two required PHD co-factors25.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [24] Pearce, E. L. & Pearce, E. J. Metabolic pathways in immune cell activation and quiescence. Immunity 38, 633–643 (2013). source
- Not checked yetcites [25] Frede, S., Stockmann, C., Freitag, P. & Fandrey, J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB. Biochem. J. 396, 517–527 (2006). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In the absence of SUCNR1 a reduction in absolute numbers of macrophages, but not inflammatory signalling, was observed and this resulted in an improvement in adipose tissue inflammation and improved glucose tolerance in mice following high-fat diet feeding.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The PHDs generate succinate from α-KG, and importantly succinate (acting via product inhibition) will inhibit the PHDs and stabilize HIF-1α21.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [21] Semenza, G. L. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24, 97–106 (2009).
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Following LPS treatment both intracellular succinate levels and the cell surface expression of SUCNR1 are increased.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinate and SUCNR1-mediated signalling in inflammation and immunity
What the sources say
- Not checked yetcites [5] Rubic, T. et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9, 1261–1269 (2008). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This modification is caused by the accumulation of succinyl-CoA, which can result from SDH inhibition and succinate accumulation38.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinylation as a covalent modification to regulate multiple targets
What the sources say
- Not checked yetcites [38] Jin, Z., Wei, W., Yang, M., Du, Y. & Wan, Y. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell. Metab. 20, 483–498 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These data suggest that complex I of the ETC is an important site of ROS production in macrophages and such ROS production may depend on RET.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These data demonstrate that succinate can have profound impacts on cellular function acting both intracellularly via ROS and HIF-1α, succinylation and histone and DNA modification and extracellularly via SUCNR1.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinylation as a covalent modification to regulate multiple targets
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Training with β-glucan was shown to be protective against Staphylococcus aureus infection and this effect was abrogated in HIF-1α-deficient mice.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between succinate, the epigenome and innate immune memory
What the sources say
- Not checked yetcites [37] El-Khoury, R. et al. Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives. Br. J. Pharmacol. 171, 2243–2249 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The authors demonstrate that SIRT5 desuccinylates and activates PKM2 and this limits IL-1β production.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinylation as a covalent modification to regulate multiple targets
What the sources say
- Not checked yetcites [46] Zhang, Z. et al. Identification of lysine succinylation as a new post-translational modification. Nat. Chem. Biol. 7, 58–63 (2011). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“DI was first employed as an experimental tool and was shown to potently induce Nrf2 and several Nrf2 target genes in control and LPS-activated BMDMs59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Lampropoulou and colleagues (2016) suggested that mechanistically the ability of itaconate to modulate inflammation arose from its ability to competitively inhibit SDH and succinate oxidation50.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an endogenous inhibitor of SDH and an anti-inflammatory metabolite
What the sources say
- Not checked yetcites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“This requires both succinate oxidation by the enzyme succinate dehydrogenase (SDH) and an increase in mitochondrial membrane potential.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [2] Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013). source
- Not checked yetcites [30] Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S. & Schumacker, P. T. Loss of the SdhB, but not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol. Cell. Biol. 28, 718–731 (2008). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Since 2016, several key studies have uncovered a role for itaconate as a crucial anti-inflammatory metabolite that negatively regulates the inflammatory response and cytokine production50,59–61, as shown in Figure 3.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an endogenous inhibitor of SDH and an anti-inflammatory metabolite
What the sources say
- Not checked yetcites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
- Not checked yetcites [61] Shin, J. H. et al. 1H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J. Proteome Res. 10, 2238–2247 (2011). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Furthermore, Irg1-deficient BMDMs, whereby genetic deletion of Irg1 completely abolished itaconate synthesis, exhibited a significant increase in the production of IL-12, IL-6, NO, and under conditions that activate the NLRP3 inflammasome, increased IL-1β and IL-1850.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an endogenous inhibitor of SDH and an anti-inflammatory metabolite
What the sources say
- Not checked yetcites [50] Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100–107 (2012). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“LPS-induced HIF-1α not only promotes glycolysis but is also directly pro-inflammatory.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“SirT5, which was previously thought to function primarily as a deacetylase has been shown to have potent desuccinylase activity 44.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinylation as a covalent modification to regulate multiple targets
What the sources say
- Not checked yetcites [44] Cheng, S. C. et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Limiting succinate oxidation with the pro-drug dimethylmalonate (DMM), which releases malonate that inhibits SDH function, profoundly represses LPS-induced HIF-1α, IL-1β and ROS and boosts IL-10 and IL-1RA.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Western blot analysis of whole cell lysates revealed that this modification is evolutionarily conserved and that substrates are numerous39 and include proteins involved in cellular metabolism38.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > Succinylation as a covalent modification to regulate multiple targets
What the sources say
- Not checked yetcites [38] Jin, Z., Wei, W., Yang, M., Du, Y. & Wan, Y. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell. Metab. 20, 483–498 (2014). source
- Not checked yetcites [39] Murphy, M. P. How mitochondria produce reactive oxygen species. Biochem. J. 417, 1–13 (2009). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“It is also important to note that itaconate is an α,β-unsaturated carbonyl compound, making it a potential Michael acceptor that could undergo nucleophilic attack by the thiolate ion of protein cysteine residues, as such the methyl esterification of the proximal carboxyl group conjugated to the alkene would be predicted to increase the electrophilicity of itaconate63.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an endogenous inhibitor of SDH and an anti-inflammatory metabolite
What the sources say
- Not checked yetcites [63] Michelucci, A. et al. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc. Natl. Acad. Sci. USA. 110, 7820–7825 (2013). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interestingly, in addition to potentiating cytokine production in response to LPS, training with β-glucan induced epigenetic upregulation of genes involved in glycolysis such as HIF-1α, Hexokinase (HK) and pyruvate kinase and increased succinate levels37.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between succinate, the epigenome and innate immune memory
What the sources say
- Not checked yetcites [37] El-Khoury, R. et al. Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives. Br. J. Pharmacol. 171, 2243–2249 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The loss of HIF-1α in macrophages decreased TNF-α, IL-1β and IL-1α production, but did not affect production of the anti-inflammatory cytokines IL-4 or IL-10 29.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
What the sources say
- Not checked yetcites [29] Mu, X. et al. Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation. Oncotarget 8, 13174–13185 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“inhibition of IκBξ by DI was shown to be mediated by activation of the transcription factor ATF3 and occur at the level of Nfkbiz translation, as assessed by eIF2α phosphorylation, in a Nrf2-independent manner60.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Supplementation of ROS in Irg1-deficient BMDMs increased A20 expression and abolished the break of endotoxin tolerance67.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [67] Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the IκBξ–ATF3 inflammatory axis. Nature 556, 501–504 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“DI is reported to selectively inhibit LPS-induced IL-6 while TNF-α levels remain unaffected”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [60] Lee, C. G., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. & O’Brien, W. E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263–270 (1995). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“4-OI was also shown to be protective in an LPS lethality model in vivo, prolonging survival, improving body temperature regulation and decreasing pro-inflammatory cytokine production59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate is an electrophilic metabolite that alkylates redox sensitive cysteines
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Intriguingly, endogenous fumarate was also found to succinate GAPDH in both mouse and human macrophages, suggesting that elevated fumarate levels may act as an endogenous anti-inflammatory signal to limit inflammation, however, the precise role of fumarate accumulation remains an open question to be explored.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“The authors proposed that fumarate accumulation acted to inhibit the KDM5 family of histone demethylases, which subsequently increased the levels of H3K4me3, a marker of active gene transcription, at the promoters of both Tnf and Il6, thus providing the first link between Krebs cycle rewiring and epigenetic regulation in an inflammatory context97.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [97] Rustin, P. et al. Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim. Biophys. Acta 1361, 185–197 (1997). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Later, it was also shown that fumarate binds glutathione (forming succinic-glutathione (succinicGSH)), and thereby depletes this antioxidant molecule leading to unscheduled oxidative stress83,84.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [83] Shi, H. Z., Wang, D., Sun, X. N. & Sheng, L. MicroRNA-378 acts as a prognosis marker and inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting IRG1. Eur. Rev. Med. Pharmacol. Sci. 22, 3837–3846 (2018).
- Not checked yetcites [84] Pan, J. et al. Immune responsive gene 1, a novel oncogene, increases the growth and tumorigenicity of glioma. Oncol. Rep. 32, 1957–1966 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This was associated with a decrease in the microRNA miR-378, which targets Irg1 as well as poorer overall survival and clinicopathological parameters.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
What the sources say
- Not checked yetcites [75] Li, Y. et al. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J. Biol. Chem. 288, 16225–16234 (2013). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“However, in 2002 it was shown that mutations of FH are the cause of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), a cancer predisposition syndrome characterised by benign tumours of the smooth muscle of skin and uterus, and a very aggressive form of renal cancer78.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [78] Cheon, Y. P., Xu, X., Bagchi, M. K. & Bagchi, I. C. Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse. Endocrinology 144, 5623–5630 (2003). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This suggestion arose from the observation that the cell-permeable fumaric esters, DMF and MMF, modify and irreversibly inhibit GAPDH enzymatic activity and aerobic glycolysis in peripheral blood mononuclear cells (PBMCs) from mice and MS patients treated with DMF99.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“suggesting there are two mechanisms for itaconate-induced Nrf2 activation; directly via KEAP1 2,3-dicarboxypropylation and indirectly via ROS production (which would then modify KEAP1)75.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mechanistically, DMF blocked the association of PKCθ with the costimulatory receptor CD28 and T cell activation.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [49] He, D. et al. Global proteome analyses of lysine acetylation and succinylation reveal the widespread involvement of both modification in metabolism in the embryo of germinating rice seed. J. Proteome Res. 15, 879–890 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“As Asl cleaves argininosuccinate into arginine and fumarate, the authors proposed that this metabolic pathway accounted for the elevated fumarate levels observed in macrophages1.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [1] Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“Blewett and colleagues (2016) demonstrated that dimethyl fumarate (DMF), a potent electrophile which is currently used to treat psoriasis and relapse-remitting MS, but not MMF inhibited the activation of human and mouse T cells 49.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [49] He, D. et al. Global proteome analyses of lysine acetylation and succinylation reveal the widespread involvement of both modification in metabolism in the embryo of germinating rice seed. J. Proteome Res. 15, 879–890 (2016). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“More recently, Kornberg and colleagues (2018) suggested that a potential consequence of elevated fumarate levels is to negatively regulate glycolysis via succination of the active site cysteine residue (C152) in GAPDH99,100.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate as a regulator of the epigenome, innate immune memory and immune cell function
What the sources say
- Not checked yetcites [99] Blatnik, M., Thorpe, S. R. & Baynes, J. W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes. Ann. NY Acad. Sci. 1126, 272–275 (2008). source
- Not checked yetcites [100] Adam, J. et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 20, 524–537 (2011). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“The effect of itaconate on ROS production is consistent with a previous study in zebrafish macrophages, which demonstrated that IRG1 was essential for OXPHOS-driven mtROS production and bactericidal killing172.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
What the sources say
- Not checked yetcites [172] Lee, J. V. et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell. Metab. 20, 306–319 (2014). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Overexpression of miR-378 suppressed glioma tumour growth both in vitro and in vivo, the epithelial-mesenchymal transition (EMT) and metastasis75.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
What the sources say
- Not checked yetcites [75] Li, Y. et al. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J. Biol. Chem. 288, 16225–16234 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Inhibition of GOT1 by aminooxyacetic acid (AOAA), which decreases D-2-HG levels, promoted expression Foxp3 and the differentiation of TH17 cells to iTregs143.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The cause of these so-called 2-hydroxyglutaric acidurias (2HGAs) was attributed to germline mutations in L-2-HG dehydrogenase (L2HGDH) and D-2-HG dehydrogenase (D2HGDH), the mitochondrial enzymes responsible for the conversion of 2-HG to α-KG and thus its breakdown107-109.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer
What the sources say
- Not checked yetcites [107] Bardella, C. et al. Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status. J. Pathol. 225, 4–11 (2011). source
- Not checked yetcites [108] Laukka, T. et al. Fumarate and succinate regulate expression of hypoxia-inducible genes via TET enzymes. J. Biol. Chem. 291, 4256–4265 (2016). source
- Not checked yetcites [109] Salminen, A., Kauppinen, A. & Kaarniranta, K. 2-Oxoglutarate-dependent dioxygenases are sensors of energy metabolism, oxygen availability, and iron homeostasis: potential role in the regulation of aging process. Cell. Mol. Life Sci. 72, 3897–3914 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, these lines of evidence provide a potential model for how fumarate accumulation promotes genomic alterations that could give rise to cancer formation in HLRCC patients, cooperating with the other above-described oncogenic signals it elicits.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Like TH17 cells, CD8+ T cells are highly dependent on the activation of HIF-1α and glycolysis, which is responsible for mediating trafficking into hypoxic tumour environments and inflamed tissue147,148.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [147] Turcan, S. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479–483 (2012). source
- Not checked yetcites [148] Wang, P. et al. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 32, 3091–3100 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Here, via its reverse activity, it generates fumarate that inhibits histone lysine demethylase KDM2B, which in turn facilitates the binding of proteins involved in DNA repair177.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [177] Valls-Lacalle, L. et al. Selective inhibition of succinate dehydrogenase in reperfused myocardium with intracoronary malonate reduces infarct size. Sci. Rep. 8, 2442 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In the case of D2HGA, about 50% of patients present with D2HGDH mutations, while the remaining half possess mutations in the Krebs cycle enzyme isocitrate dehydrogenase 2 (IDH2), which converts isocitrate to α-KG110.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer
What the sources say
- Not checked yetcites [110] Isaacs, J. S. et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell. 8, 143–153 (2005). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“T-helper 17 (TH17) cells, derived from naïve CD4+ T cells, are one such subset that rely heavily on a switch from OXPHOS to glycolysis, a process that requires the activation of HIF-1α and induction of RORγt143,146.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
- Not checked yetcites [146] Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 17, 510–522 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Consistent with an important role of senescence bypass for the development of tumorigenesis, recent data in HLRCC patients showed that CDKN2A (also known as P16), a key player in senescence, is hypermethylated and suppressed in tumours85.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [85] Frezza, C. Mitochondrial metabolites: undercover signalling molecules. Interface Focus 7, 20160100 (2017). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The elevated levels of D-2-HG was associated with increased DNA methylation levels at the Foxp3 locus, the master transcription factor driving iTreg differentiation, resulting in its repression143.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, TH17 cell differentiation could be initiated by exogenous addition of D-2-HG to naïve CD4+ T cells or by genetic silencing of TET1 and TET2, established targets of 2-HG143-145.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [143] Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009). source
- Not checked yetcites [144] Chowdhury, R. et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12, 463 (2011). source
- Not checked yetcites [145] Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell. 19, 17–30 (2011). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Upon DNA damage, FH localises in the nucleus, where it is phosphorylated by the catalytic subunit of DNA-PK (DNA-PKcs)177.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [177] Valls-Lacalle, L. et al. Selective inhibition of succinate dehydrogenase in reperfused myocardium with intracoronary malonate reduces infarct size. Sci. Rep. 8, 2442 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In support of this unexpected function of fumarate, it was recently shown that the aberrant accumulation of this metabolite in HLRCC correlates with increased endogenous damage, lower DNA repair efficiency and increased sensitivity to poly-ADP ribose polymerase (PARP) inhibitors178.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Fumarate, a mitochondrial messenger of the immune system and tumor microenvironment > Fumarate and cellular transformation
What the sources say
- Not checked yetcites [178] Kohlhauer, M. et al. Metabolomic profiling in acute ST-segment-elevation myocardial infarction identifies succinate as an early marker of human ischemia-reperfusion injury. J. Am. Heart Assoc. 7, e007546 (2018). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Although the IC50 of D-2-HG toward KDM family members is in the low micromolar range (24-106 μM), it can also inhibit FIH and PHD2, with IC50 values of 1.5 and 7.3 mM, respectively121.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mechanistically, HIF-1α stabilisation induced LDHA expression and activity, which promiscuously converted glutamine-derived α-KG to L-2-HG149.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“D-2-HG produced by mIDH1/2 has been shown to drive a CpG island methylator phenotype (G-CIMP) in both glioma and ICC tumours to promote tumorigenesis, and has also been found to occupy the active site of histone demethylases thereby increasing histone methylation in primary gliomas121,123-125.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [121] Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H. & Wadman, S. K. l-2-Hydroxyglutaric aciduria: an inborn error of metabolism? J. Inherit. Metab. Dis. 3, 109–112 (1980). source
- Not checked yetcites [123] Rzem, R. et al. A gene encoding a putative FAD-dependent l-2-hydroxyglutarate dehydrogenase is mutated in l-2-hydroxyglutaric aciduria. Proc. Natl. Acad. Sci. USA 101, 16849–16854 (2004). source
- Not checked yetcites [124] Struys, E. A. et al. Mutations in the d-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 76, 358–360 (2005). source
- Not checked yetcites [125] Topçu, M. et al. l-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum. Mol. Genet. 13, 2803–2811 (2004). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The authors demonstrate that this is independent of IDH1 and 2 and primarily mediated by LDHA and malate dehydrogenase (MDH) via “promiscuous” reduction of αKG and this is enhanced by acidic pH52.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [52] Wang, Y. et al. KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase. Nature 552, 273–277 (2017). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This metabolic rewiring resulted in a decrease in a common dipeptide found in the brain N-acetyl-aspartyl-glutamate (NAAG), and NAAG levels were found to be significantly lower in IDH-mutant human glioma tissue134.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [134] Figueroa, M. E. et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 18, 553–567 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As such, these findings directly link mIDH-derived D-2-HG accumulation to DNA damage, genetic instability and carcinogenesis.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Indeed, D-2-HG accumulation in IDH-mutant glioma has been found to inhibit PHD hydroxylase and stabilise HIF-1α126 and HIF-1αstabilisation has been shown to occur in IDH1-mutant brain tissue127.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [126] Kranendijk, M. et al. IDH2 mutations in patients with d-2-hydroxyglutaric aciduria. Science 330, 336 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Genomic studies have established that somatic mutations in IDH1 and IDH2 are perhaps the first genetic events to occur during tumorigenesis in human glioma and AML, and appear to initiate pathogenesis by a common mechanism103,115-117.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [103] Linehan, W. M. et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med. 374, 135–145 (2016). source
- Not checked yetcites [115] Yogev, O. et al. Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol. 8, e1000328 (2010). source
- Not checked yetcites [116] Jiang, Y. et al. Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. Nat. Cell Biol. 17, 1158–1168 (2015). source
- Not checked yetcites [117] Sulkowski, P. L. et al. Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair. Nat. Genet. 50, 1086–1092 (2018). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Under acidic conditions αKG is protonated and this promotes binding to LDHA and L-2HG production.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [52] Wang, Y. et al. KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase. Nature 552, 273–277 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Indeed, IDH-mutant cells display reduced DNA repair kinetics, accumulate DNA double stranded breaks (DSBs) and are sensitized to alkylating agents131,174.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [131] MacIver, N. J., Michalek, R. D. & Rathmell, J. C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31, 259–283 (2013). source
- Not checked yetcites [174] Mi, W. et al. YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer. Nat. Commun. 8, 1088 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“the concentrations at which it accumulates under pathogenic conditions suggests HIF-1α stabilisation and impaired collagen biogenesis may contribute to tumorigenicity126-130.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [126] Kranendijk, M. et al. IDH2 mutations in patients with d-2-hydroxyglutaric aciduria. Science 330, 336 (2010). source
- Not checked yetcites [127] Nota, B. et al. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined d-2- and l-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 92, 627–631 (2013). source
- Not checked yetcites [128] Dang, L. & Su, S. M. Isocitrate dehydrogenase mutation and R-2-hydroxyglutarate: from basic discovery to therapeutics development. Annu. Rev. Biochem. 86, 305–331 (2017). source
- Not checked yetcites [129] Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058–1066 (2009). source
- Not checked yetcites [130] Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–1812 (2008). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This increase occurred under normoxic conditions and was dependent on HIF-1α stabilisation149.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > 2-HG as an epigenetic modifier that governs T cell differentiation
What the sources say
- Not checked yetcites [149] Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Functionally, L-2HG is both sufficient to try histone methylation, in particular histone 3 lysine 9 (H3K9me3), and can also promote HIF-1α stabilization in normoxia and therefore may assist with hypoxic adaptation.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [51] Du, J. et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806–809 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Remarkably, almost all IDH1/2 mutations occur in a few unique locations in the active site of the enzymes, which results in the acquirement of a neomorphic enzymatic activity converting α-KG to the oncometabolite D-2-HG118-120.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > D-2-HG-inhibition of αKGDD and tumorigenesis as a consequence of IDH mutations
What the sources say
- Not checked yetcites [118] Johnson, T. I., Costa, A. S. H., Ferguson, A. N. & Frezza, C. Fumarate hydratase loss promotes mitotic entry in the presence of DNA damage after ionising radiation. Cell Death Dis. 9, 913 (2018). source
- Not checked yetcites [119] Ye, D., Guan, K. L. & Xiong, Y. Metabolism, activity, and targeting of d- and l-2-Hydroxyglutarates. Trends Cancer 4, 151–165 (2018). source
- Not checked yetcites [120] Chalmers, R. A. et al. d-2-hydroxyglutaric aciduria: case report and biochemical studies. J. Inherit. Metab. Dis. 3, 11–15 (1980). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Citrate, a component of the TCA cycle has been shown to act as a source of acetyl-CoA to drive histone acetylation and this process can have profound impacts on both tumor and immune cell function.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation
What the sources say
- Not checked yetcites [53] Gibson, G. E. et al. α-ketoglutarate dehydrogenase complex–dependent succinylation of proteins in neurons and neuronal cell lines. J. Neurochem. 134, 86–96 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“D-2-HG has also been found to bind the DNA methyltransferase DNMT1, which subsequently represses receptor-interacting protein kinase 3 (RIP3).”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [140] Watanabe, T., Nobusawa, S., Kleihues, P. & Ohgaki, H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am. J. Pathol. 174, 1149–1153 (2009). source
- Not checked yetcites [141] Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mechanistically LDHA-deficient T cells showed decreased acetyl-CoA levels and decreased histone H3 acetylation at the lysine 9 residue (H3K9Ac), a histone mark associated with active transcription, on the Ifng promoter.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA and histone acetylation regulate of immune cell function
What the sources say
- Not checked yetcites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“One of the earliest studies to identify a role for ACL in histone acetylation demonstrated a requirement for this gene in response to growth factor stimulation and during differentiation, for example the differentiation of murine 3T3- L1 pre-adipocytes into adipocytes.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation
What the sources say
- Not checked yetcites [54] Wang, F. et al. SIRT5 desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1β production and to prevent dss-induced colitis in mice. Cell Rep. 19, 2331–2344 (2017). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Finally, D-2HG also impairs necroptosis and the small GTPase Cdc42, leading to suppression of mixed lineage kinase 3 (MLK3)-mediated apoptosis140,141.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [140] Watanabe, T., Nobusawa, S., Kleihues, P. & Ohgaki, H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am. J. Pathol. 174, 1149–1153 (2009). source
- Not checked yetcites [141] Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Furthermore, artificial acetyl-CoA reduction, through inhibition of ACLY, decreased IFN-γ expression and acetate supplementation, which augmented acetyl-CoA production, corrected H3K9Ac marks and IFN-γ expression in LDHA-deficient T cells.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA and histone acetylation regulate of immune cell function
What the sources say
- Not checked yetcites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“It has been demonstrated in mammalian cells that histone acetylation is dependent on ACL, the enzyme that converts citrate into acetyl-CoA, a required co-factor for acetylation,54 with ACL silencing decreasing the degree of histone acetylation.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation
What the sources say
- Not checked yetcites [54] Wang, F. et al. SIRT5 desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1β production and to prevent dss-induced colitis in mice. Cell Rep. 19, 2331–2344 (2017). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“ACLY deficiency results in impaired BRCA1 recruitment to sites of DSBs and suppression of homologous recombination.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA alters the epigenome of tumor cells
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“ACLY is phosphorylated downstream of AKT activation, following DNA damage and this facilitates histone acetylation at double strand break (DSB) sites, enabling breast cancer early onset 1 (BRCA1) recruitment and DNA repair by homologous recombination.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA alters the epigenome of tumor cells
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The production of succinate is also enhanced during inflammation13, acting as a signal from mitochondria to the cytosol to activate pro-inflammatory gene expression while also generating ROS as a further pro-inflammatory redox signal28.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [13] van Diepen, J. A. et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia 60, 1304–1313 (2017). source
- Not checked yetcites [28] Rasola, A., Neckers, L. & Picard, D. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells. Trends Cell Biol. 24, 455–463 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mice with an T cell-specific LDHA deficiency produced less IFN-γ and were protected from immunopathology.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Citrate and ATP-citrate lyase as a source of acetyl-CoA for histone acetylation > Acetyl-CoA and histone acetylation regulate of immune cell function
What the sources say
- Not checked yetcites [55] Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274–14284 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“D-2-HG has also been found to be a competitive inhibitor of SDH, a key metabolic enzyme and tumour suppressor as previously discussed, resulting in the accumulation of succinate, impaired mitochondrial oxygen consumption and increased protein succinylation139.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [139] Suzuki, H. et al. Mutational landscape and clonal architecture in grade II and III gliomas. Nat. Genet. 47, 458–468 (2015). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“D-2-HG activates NF-κB in bone marrow stromal cells in an IκB kinase-independent fashion, thus generating a stromal niche for IDH mutant AML development138.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > 2-hydroxyglutarate in immunity and cancer > The role of alternative D-2-HG targets in cancer initiation and progression
What the sources say
- Not checked yetcites [138] Finlay, D. K. et al. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 209, 2441–2453 (2012). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Inhibitors of α-KGDDs are often non-specific, either hitting multiple isoforms or a-KGDD family members, such as dimethyloxaloylglycine (DMOG) acting on TETs but also PHDs [7].”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [7] Nadjsombati, M. S. et al. Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit. Immunity 49, 33–41.e7 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“However, specific PHD inhibitors have been developed, such as Vadadustat, and have shown promise in chronic kidney disease, increasing erythropoiesis and providing a means of attenuating HIF in other pathologies [10].”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [10] Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“a drug Enasidenib has been developed for AML, which binds to the mutated, but not the wild-type, form of IDH2 only to prevent D-2-HG production163.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [163] Chen, J. Y. et al. The oncometabolite R-2-hydroxyglutarate activates NF-κB-dependent tumor-promoting stromal niche for acute myeloid leukemia cells. Sci. Rep. 6, 1 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“One critical point to consider is the limited human and in vivo data existing to date.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Outstanding questions and concluding remarks
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Studies in human immune cells are also currently very limited.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Outstanding questions and concluding remarks
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“succinate, which promotes a potentially tumour-fighting, pro-inflammatory state also drives HIF-1α activation in tumours which is associated with cancer progression.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Outstanding questions and concluding remarks
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one.
In the paper
“4-OI is an itaconate mimic that was protective in a mouse model of sepsis, decreasing cytokine production and increasing survival59.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
What the sources say
- Not checked yetcites [59] Okabe, M., Lies, D., Kanamasa, S. & Park, E. Y. Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus. Appl. Microbiol. Biotechnol. 84, 597–606 (2009). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Alternatively, the nervous system coordinates whole‐body metabolism not only by the production of neurohormones that act locally, but also by direct innervation of the target tissues 2, 3, 4, 5.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Introduction
“As such, the reaction catalysed by OGDH is referred to as substrate level phosphorylation and constitutes the fifth step in the Krebs cycle.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Introduction
“In the fourth step, OGDH catalyses the oxidative decarboxylation of α-KG to form succinyl-CoA, NADH and CO2. Succinyl-CoA synthetase then catalyses the hydrolysis of succinyl-CoA, coupled to the condensation of GDP and inorganic phosphate (Pi), or ADP and Pi, to form succinate and either GTP or ATP.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Itaconate as a key anti-inflammatory metabolite and novel player in tumor biology > Itaconate in macrophage-tumor crosstalk
“Furthermore, Weiss and colleagues (2018) demonstrated that ROS production in response to itaconate regulates Nrf2, suggesting there are two mechanisms for itaconate-induced Nrf2 activation; directly via KEAP1 2,3-dicarboxypropylation and indirectly via ROS production (which would then modify KEAP1)75.”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > References
“75. Shi H Wang D Sun X S L MicroRNA-378 acts as a prognosis marker and inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting IRG1 Eur Rev Med Pharmacol Sci 2018 6 22 12 3837 3846 10.26355/eurrev_201806_15268 2018 29949160”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Therapeutic opportunities
“However, specific PHD inhibitors have been developed, such as Vadadustat, and have shown promise in chronic kidney disease, increasing erythropoiesis and providing a means of attenuating HIF in other pathologies [10].”
§ Coupling Krebs cycle metabolites to signalling in immunity and cancer > Succinate as a signal in macrophages and tumour cells > The interplay between hypoxia-inducible factor 1 and succinate in inflammatory signalling and tumorigenesis
“In the presence of oxygen, conserved proline residues in the HIF-1α subunit are hydroxylated by PHD 1, 2 and 3 16. Hydroxylation provides a recognition site for the binding of Von Hippel-Lindau (VHL) E3 ubiquitin ligase, which ubiquitinates HIF-1α and subsequently targets it for proteasomal degradation17.”
Citations
Cites
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Cappello, V., Marchetti, L., Parlanti, P., Landi, S., Tonazzini, I., Cecchini, M., Piazza, V., & Gemmi, M. (2016) · Scientific Reports · doi:10.1038/s41598-016-0001-8 · Cited by 13,097
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Self-citationAn Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Self-citationCancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148
Cited by
Sorted by citations
Cellular Adaptation to Hypoxia through Hypoxia Inducible Factors and beyond
Lee, P., Chandel, N. S., & Simon, M. C. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0227-y · Cited by 1,272
The assembly, regulation and function of the mitochondrial respiratory chain
Vercellino, I., & Sazanov, L. A. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00415-0 · Cited by 1,015
Therapeutic targeting of the hypoxic tumour microenvironment
Singleton, D. C., Macann, A., & Wilson, W. R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00539-4 · Cited by 507
Reactive Oxygen Species in Macrophages: Sources and Targets
Canton, M., Sánchez‐Rodríguez, R., Spera, I., Venegas, F. C., Favia, M., Viola, A., & Castegna, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.734229 · Cited by 490
Cancer cell metabolism and antitumour immunity
Martino, M. D., Rathmell, J. C., Galluzzi, L., & Vanpouille‐Box, C. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01026-4 · Cited by 385
Metadata
- Authors
- Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L.
- Affiliations
- Trinity College Dublin (IE)
- University of Cambridge (GB)
- Harvard University (US)
- ORCID
- Venue
- Nature Metabolism
- Published
- 2018-12-30
- Volume
- 1
- Issue
- 1
- Pages
- 16-33
- ISSN
- 2522-5812 (ISSN-L)
- PMC
- PMC6485344
- OpenAlex
- W2907926991
- Semantic Scholar
- b15b8b89360b980cc180d451684d173275b9488c
- Cited by
- 398
- References
- 204
- Citations by year
- 2026: 35 · 2025: 39 · 2024: 70 · 2023: 41 · 2022: 66 · 2021: 66 · 2020: 61 · 2019: 20
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (110158/Z/15/Z, 205455, 110159/Z/ 15/Z, 109443/Z/15/Z)
- Medical Research Council (MC_UU_00015/3, MC_UU_12022/6)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- Krebs cycle metabolites, metabolic reprogramming, succinic acid, fumarate, itaconate, 2-hydroxyglutarate, acetyl-CoA, immune cell function, cancer, carcinogenesis, tumor immunology, therapeutic target
- MeSH terms
- Citric Acid Cycle, Humans, Immunity, Innate, Macrophages, Neoplasms, Succinate Dehydrogenase, Succinates, Signal Transduction, Succinic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review